Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9304
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 114 $1,321,257 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $1,321,257 Current and potential, with all options
- Last date to order 84% complete
- IDV ceiling 26% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.
The IDC, awarded under the SPE2DB program, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract enables the DLA to issue firm fixed-price delivery orders for these pharmaceutical items to support the medical supply requirements of Department of Defense (DoD) and other government agency customers globally, including planned and unplanned contingency operations. The contract has a base period of 30 months and three 30-month option periods, aligning with the DLA's larger Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition strategy, which aims to establish multiple regional pharmaceutical prime vendor contracts with an estimated total value of $30.3 billion.
Task orders
Show 40 more
Latest 50 of 114 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9304?
SPE2DR25D9304 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D9304 worth?
Orders under SPE2DR25D9304 have obligated $1,321,257. SPE2DR25D9304's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9304?
114 orders have been placed under SPE2DR25D9304, the latest on July 29, 2026.
Who can order from contract SPE2DR25D9304?
SPE2DR25D9304 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9304 competed?
The extent of competition for SPE2DR25D9304 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV